CONMED Corp - Common Stock (CNMD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CNMD on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
31.3M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
34.8M
Holdings value
$1.63B
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
265
Number of buys
132
Number of sells
-145
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CONMED Corp - Common Stock (CNMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.1% $244M 4.68M BlackRock, Inc. 30 Jun 2025
FULLER & THALER ASSET MANAGEMENT, INC. 5.63% $94.1M 1.74M Fuller & Thaler Asset Management, Inc. 30 Jun 2025
Capital Research Global Investors 3.3% $48.6M 1.03M Capital Research Global Investors 30 Sep 2025

Institutional Holders of CONMED Corp - Common Stock (CNMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 34.8M $1.63B -$23.6M $47.03 265
2025 Q2 35M $1.82B -$41.4M $52.08 274
2025 Q1 35.6M $2.15B -$20.5M $60.39 278
2024 Q4 35.8M $2.45B +$126M $68.44 278
2024 Q3 33.9M $2.44B -$124M $71.92 288
2024 Q2 35.7M $2.48B -$1.09M $69.32 290
2024 Q1 35.6M $2.85B -$67.9M $80.08 291
2023 Q4 36.1M $3.95B +$63.2M $109.51 304
2023 Q3 35.6M $3.59B +$9.28M $100.85 272
2023 Q2 35.2M $4.78B -$128M $135.89 260
2023 Q1 36.3M $3.77B +$69.5M $103.86 230
2022 Q4 36.1M $3.2B +$90.5M $88.64 237
2022 Q3 35.2M $2.82B +$50.4M $80.17 238
2022 Q2 33.9M $3.25B +$139M $95.76 271
2022 Q1 32.3M $4.79B +$14.7M $148.55 269
2021 Q4 32.2M $4.56B +$83.1M $141.76 259
2021 Q3 31.5M $4.13B +$14.8M $130.83 257
2021 Q2 31.4M $4.32B +$62.1M $137.43 248
2021 Q1 31M $4.05B +$77.3M $130.59 236
2020 Q4 30.8M $3.45B +$80.5M $112.00 241
2020 Q3 30.3M $2.38B +$64.4M $78.67 232
2020 Q2 29.5M $2.13B +$45.2M $71.99 220
2020 Q1 29.4M $1.68B -$49.8M $57.27 217
2019 Q4 29M $3.25B +$3.75M $111.83 261
2019 Q3 29M $2.79B -$21.5M $96.15 230
2019 Q2 29.2M $2.5B +$41.1M $85.57 224
2019 Q1 29.1M $2.42B +$177M $83.18 219
2018 Q4 27.2M $1.75B -$29.9M $64.20 204
2018 Q3 27.5M $2.18B -$3.75M $79.22 203
2018 Q2 27.6M $2.02B +$30M $73.20 193
2018 Q1 27.3M $1.73B -$35.4M $63.33 169
2017 Q4 27.9M $1.42B -$13.3M $50.97 154
2017 Q3 28.1M $1.47B +$15.4M $52.47 142
2017 Q2 27.8M $1.42B -$5.22M $50.94 147
2017 Q1 28.1M $1.25B +$137M $44.41 141
2016 Q4 28M $1.24B -$12.2M $44.17 146
2016 Q3 28.3M $1.13B -$5.77M $40.06 144
2016 Q2 28.2M $1.35B +$34.5M $47.73 151
2016 Q1 27.7M $1.16B +$3.23M $41.94 157
2015 Q4 27.5M $1.21B +$1.06M $44.05 151
2015 Q3 27.5M $1.31B -$13.2M $47.74 154
2015 Q2 27.2M $1.58B +$20.5M $58.27 155
2015 Q1 26.9M $1.36B +$39.6M $50.49 146
2014 Q4 26.3M $1.18B +$23.6M $44.96 155
2014 Q3 23.9M $881M -$4.22M $36.84 161
2014 Q2 23.6M $1.04B -$50.8M $44.15 178
2014 Q1 24.7M $1.07B -$55.8M $43.45 172